The news story you are looking for has expired. A more recent related article is displayed below.

Sponsored Links

ZoomMed's "ZRx Pharma", the New Communication Media Creates Consensus Among Canadian Pharmaceutical Corporations

ZoomMed Inc. (TSX VENTURE:ZMD), developer of the ZRx Prescriber intended for physicians, The e-Pic communication network and the ZRx Pharma intercommunication system is proud to announce the signing of multiple agreements with different Canadian pharmaceutical corporations, for the use of ZoomMed's new pharmaceutical information communication tool, known as the "ZRx Pharma".

The aggregate amount of those contracts represents 1 million dollars since the beginning of its fiscal year started June 1st, 2009. To this day, 11 Pharmaceutical Corporations are using the ZRx Pharma intercommunication system.

"We actually reached a critical mass of 3,000 physicians who have chosen our ZRx Prescriber and that number is continuously growing. Reaching this critical mass enables us to tackle the next steps of our business plan, steps that will be marked by important revenue growth coming from pharmaceutical corporations and pharmacy chains." declared Mr. Yves Marmet, President and Chief Executive Officer of ZoomMed.

"New pharmaceutical products are launched every year. Unfortunately, physicians have less and less time to meet with pharmaceutical representatives. Wireless Internet connections, the introduction and increased use of pocket computers and smart phones have given rise to a host of solutions that were once unimaginable. Since its launch two years ago, the ZRx Pharma intercommunication system is now well recognized as an efficient solution, providing great added values to communication efforts made by small and large pharmaceutical corporations in order to reach physicians" added Mr. Marmet.

About the ZRx Pharma system

ZRx Pharma, the new revolutionary communication tool allows information intercommunication between pharmaceutical corporations and physicians using the ZRx Prescriber, such as; continuing medical education, new product launches, medical training, major medical alerts, clinical studies and surveys.

About the ZRx Prescriber

ZoomMed developed the ZRx Prescriber, a technological innovative Web application that enables physicians to use a wireless device, such as the IPod Touch(TM), IPhone(TM), other PDA's or computers, to write and rapidly deliver scripts. The ZRx Prescriber is quick, efficient and intuitive. Since it is a stand-alone product, it can easily be integrated to any Electronic Medical Record application (EMR).

About the e-Pic communication network

ZoomMed's e-Pic communication network allows intercommunications between physicians who use the ZRx Prescriber and pharmacists who are members of the network. Thus, physicians and pharmacists can transfer, capture (scan), and electronically receive prescription information and prescription renewal information through this high speed and entirely secure network.

SOURCE: ZoomMed inc.

ZoomMed inc.
Mr. Yves Marmet
President and Chief Executive Officer
450-678-5457, Ext 228
info@zoommed.com
www.zoommed.com

Copyright (C) 2009 Marketwire Canada. All rights reserved

News Provided by COMTEX


Related terms: business, canada, ceo, clinical, education, internet, media, medical, new product, pharmaceuticals, pharmacy, physicians, president, products, revenue, training, web, wireless

Related Articles

Patheon announces end to discussions with white knight bidder Lonza Group | Markets | Headline News
Oct 20, 2009
...JLL Partners in its protracted hostile takeover bid for Canadian pharmaceutical products company Patheon Inc. (TSX:PTI...Lonza's US$485-million takeover proposal for the Canadian pharmaceutical products company. Patheon officials have refused...

Hard To Treat Diseases (HTDS) Set To Release Its 90 - 180 Day Forward Guidance, With A Launch On
Oct 13, 2009
...days. More importantly the company will be meeting early next week with the principal representatives of the Canadian Pharmaceutical company in Belgrade Serbia in regards to the Slavica Bio Chem's MindUp cancer project and its planned split...

Nuvo announces 2009 third quarter financial results
Oct 28, 2009
...portfolio of topical and transdermal products targeting a variety of indications. Nuvo is a publicly traded, Canadian pharmaceutical company headquartered in Mississauga, Ontario , with manufacturing facilities in Varennes , Quebec...

McAfee warns on dangers of branded spam - Computer Business Review : News
Oct 12, 2009
...costing them prestige, customers, and revenue. Research by the security software and services vendor showed Canadian pharmaceutical spam accounted for 70% of all spam, which now accounts for 19 of every 20 emails. Share this article...